Medtronic reports second quarter fiscal 2023 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Medtronic dips on miss and lower guidance from slow procedure and supply recovery
November 22, 2022 9:01 AM ESTMedtronic (NYSE: MDT) fell nearly 5% in pre-open trading Tuesday following a miss on the top-line for the second quarter and lower full-year guidance.
The medical device maker reported that revenue fell 3% to $7.6 billion, missing the Wall Street consensus of $7.7 billion. The company said the results reflect "slower supply recovery or lower than anticipated underlying market procedure volumes in certain businesses and... More
Medtronic (MDT) Tops Q2 EPS by 2c; Guides FY23 EPS Below the Street
November 22, 2022 6:49 AM ESTMedtronic (NYSE: MDT) reported Q2 EPS of $1.30, $0.02 better than the analyst estimate of $1.28. Revenue for the quarter came in at $7.6 billion versus the consensus estimate of $7.7 billion.
GUIDANCE:
Medtronic sees FY2023 EPS of $5.25-$5.30, versus the consensus of $5.53. The company... More
